Ligand · MBU
MBU · (5P)-2-[(S)-cyclopropyl(4-methylpyridin-2-yl)methyl]-5-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-[(2-methyl-1H-imidazol-1-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one
MBU, (5P)-2-[(S)-cyclopropyl(4-methylpyridin-2-yl)methyl]-5-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-[(2-methyl-1H-imidazol-1-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one (C30 H31 F3 N6 O, 548.6 g/mol), in the MolNFT structures on…
- Component
- MBU
- Formula
- C30 H31 F3 N6 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
MBU in 2 structures; the first of them:
- 7UAS · Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a… · MBU A401 · binds ALA47, VAL48, SER49, ALA65, GLY89, ILE90, SER91, ASP92 and 16 more
- 7UAS · Discovery of potent orally bioavailable wd repeat domain 5 (WDR5) inhibitors using a… · MBU A401 · binds ALA47, VAL48, SER49, ALA65, GLY89, ILE90, SER91, ASP92 and 16 more
Residues it binds most
PHE 4, ILE 4, SER 4, ALA 4, ASP 4, TYR 4, VAL 4, CYS 4, GLY 4, LEU 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.